Efficacy and Safety of the Fixed-Dose Combination of Atorvastatin/Fenofibrate Versus Atorvastatin on the Lipid Profile of Patients with Type 2 Diabetes and Dyslipidemia

Efficacy and Safety of the Fixed-Dose Combination of Atorvastatin/Fenofibrate Versus Atorvastatin on the Lipid Profile of Patients with Type 2 Diabetes and Dyslipidemia

Abstract Introduction In dyslipidemia associated with type 2 diabetes (T2DM), elevated triglycerides (TG), increased low-density lipoprotein cholesterol (LDL-C), and decreased high-density lipoprotein cholesterol (HDL-C) levels are commonly found, resulting in a high prevalence of mixed dyslipidemia...

Full description

Saved in:
Bibliographic Details
Main Authors: Francisco G. Padilla-Padilla, Lina N. Ruiz-Bernes, Luis M. Román-Pintos, Juan A. Peraza-Zaldívar, José G. Sander-Padilla, Laura A. Lugo-Sánchez, Kevin F. Rios-Brito, María M. Arguedas-Núñez, Diana Flores-Huanosta, Jorge González-Canudas
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-05-01
Series:Cardiology and Therapy
Subjects:
Dyslipidemias
Type 2 diabetes
Fixed-dose combination
Atorvastatin
Triglycerides
Fenofibrate
Online Access:https://doi.org/10.1007/s40119-025-00410-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s40119-025-00410-y

Similar Items